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Abstract
Background: Malaria is a leading cause of morbidity and mortality among young children and is estimated to
cause at least 1 million deaths each year especially among pregnant women and young children under the age of
five years. Vitamin A supplementation is known to reduce morbidity and mortality in young children. Zinc is
required for growth and immunity and we sought to replicate the study by Zeba et al. which showed 30% lower
cases of clinical malaria in children on a combination of zinc and a large dose of vitamin A compared with children
on vitamin A alone based on the hypothesis that combined vitamin A and zinc reduced symptomatic malaria
compared to vitamin A alone.
Objectives: The primary objective was to determine the effect of vitamin A alone vs. vitamin A and zinc
supplements on the incidence of clinical malaria and other anthropometric indices. It also sought to assess the
effects on the incidence of anaemia, diarrhoea and pneumonia.
Methods: The study was community-based and 200 children between the ages of 6–24 months were randomised
to receive either vitamin A (100,000 IU for infants less than 12 months & 200,000 IU for children greater than
12 months and 10 mg daily zinc in the intervention group or vitamin A and zinc placebo for 6 months in the
control group.
Results: The number of children who were diagnosed with uncomplicated malaria in the intervention group was
27% significantly lower compared with the children in the control group (p = 0.03). There were, however, no effects
on severe malaria, pneumonia, anaemia and diarrhea.
Conclusions: Our study confirms a significant role of vitamin A and zinc in reducing malaria morbidity.
Keywords: Vitamin A, Zinc, Malaria, Morbidity, MRDR
Introduction
Malaria is a leading cause of morbidity and mortality
among young children and imposes a substantial eco-
nomic and social burden [1]. It is estimated to cause at
least 1 million deaths each year especially among preg-
nant women and young children under the age of five
years. It causes chronic anaemia, impaired growth and
delayed development in young children [2].
The health of children is also affected by lack of ad-
equate micronutrients [3] hence home fortification may
help improve their micronutrient status [4,5]. Vitamin A
supplementation is known to reduce morbidity [6,7] and
mortality [8] in children. As vitamin A status of people
in developing countries is tenuous, high dose supple-
ments are an effective means to avoid the harmful ef-
fects of vitamin A deficiency [9] that results in impaired
immune function and an increased risk of death [10].
Malnutrition creates an increased risk of mortality from
malaria due to deficiencies of critical micronutrients,
such as iron, vitamin A, and zinc [11]. Zinc is required
for growth and immunity as well as protein synthesis
[12]. Potential consequences of zinc deficiency include
compromised immune function, increased rates of ser-
ious infectious diseases, and impaired growth [13].
The problem of micronutrient deficiency affects many
developing countries such as Ghana. A study in 2008 by
Zeba et al. in neighbouring Burkina Faso assessed
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potential benefits of combining zinc and a large dose of
vitamin A. The authors hypothesized that children up to
6 years of age receiving combined vitamin A and zinc
supplements will have a lower incidence of symptomatic
malaria than similar children receiving vitamin A sup-
plements alone. That study, carried out among children
between the ages of 6 and 72 months, demonstrated a
significant decrease in the incidence of malaria in the
supplemented group compared with the placebo group
and a delay in subsequent malaria attacks [14].
Our study sought to investigate whether the findings
from Zeba et al. (2008) using the combination of vitamin
A and zinc supplements could be further elucidated in
younger children between the ages of 6 and 24 months,
who are mostly fed weaning foods, to demonstrate if there
will be an impact on overall morbidity and/or anthropo-
metric indices. The primary objective of this study was to
determine the effect of vitamin A alone vs. vitamin A and
zinc supplements on the incidence of clinical malaria. In
addition, we determined the effects of vitamin A alone vs.
vitamin A and zinc supplements on changes in anthropo-
metric measurements, such as weight and length/height,
as well as assessing the effect of the study interventions on
the incidence of anemia, diarrhea and pneumonia. The
tolerability of the supplements was also assessed. We de-
termined the change in zinc status by measuring plasma
zinc concentration using atomic absorption spectrometry
before and after supplementation. Finally, the changes in
vitamin A status were assessed by using the modified rela-
tive dose response (MRDR) test during and at the end of
the intervention.
Methods
Study site
The study was part of a multi-country, longitudinal,
placebo-controlled randomised trial involving four coun-
tries in Central (Cameroon) and West Africa (Burkina
Faso, Ghana and Mali). In Ghana, the study was
conducted in 12 randomly selected communities located
in a rural area of the Kintampo North Municipality in
the Brong Ahafo Region of Ghana. The Kintampo North
Municipality has a resident population of about 80,000;
majority of whom have a relatively poor socioeconomic
status. Previous studies carried out in the Kintampo area
indicate severe vitamin A deficiency with 51% of chil-
dren under 5 years having serum retinol ≤0.70 μmol/L
[15]. Previous anthropometric data indicated a preva-
lence of stunting of 32% and wasting of 4% among chil-
dren aged 12 months [16].
Study design
Participants and study interventions
This was a community-based study involving 200 ran-
domly selected infants between the ages of 6 and
24 months who were identified from 12 randomly se-
lected communities using listings generated from the
Kintampo Health Demographic Surveillance System
(KHDSS) database [17]. A screening form was adminis-
tered by trained field workers to mothers in the commu-
nities to identify eligible children for the study. The
child of each consenting mother was issued a study ID
card containing identification information to be used by
trained field staff to identify the child and replenish their
weekly supply of zinc/placebo. The study was double
blind and eligible children were randomised to receive
10 mg daily zinc gluconate or zinc placebo (maize pow-
der) for 6 months. Mothers were instructed to mix a
capsule of zinc/placebo with a small amount of food to
be given to the child. Mothers were not prevented from
breastfeeding their infants during the period of supple-
mentation. Where there were at least two eligible chil-
dren in a household only one child was randomly
selected to avoid contamination.
Enrolment
200 infants were recruited and haemoglobin determin-
ation was done for all 200 infants at baseline. Blood
spots on filter paper were taken from the blood which
was collected for malaria parasite assessment for all 200
children. This was followed by vitamin A dosing which
started on 30th March 2009. Children less than
12 months of age received 100,000 IU vitamin A and
children ≥12 months received 200,000 IU vitamin A at
the beginning of the study and at the end of the period
of zinc supplementation. After a period of 30 days ±
7 days 3mls of venous blood samples were taken from
all available children for vitamin A and zinc analyses.
The first week of zinc/placebo supplementation started
in May 2009 and continued for 6 months. In all, 18 chil-
dren were lost to follow up and a second set of 3mls of
venous blood samples was collected for the remaining
182 children Figure 1 (92 in the vitamin A and zinc
group and 90 in the vitamin A and placebo group)
followed by anthropometric measurements. The field
work component of the study was successfully com-
pleted in November 2009. A third and final anthropo-
metric measurement was carried out 6 months later in
May 2010 to assess whether there were any long-term
benefits of supplementation with vitamin A and zinc.
Eligibility
The inclusion of children into the study was based on the
child falling in the age group 6 to 24 months, the guardian
willing to provide informed consent and the child’s care-
giver planning to remain resident in the study area during
the study period (at least 7 months). Children were ex-
cluded from participation in the study if they were found
to have clinical evidence of vitamin A deficiency, severe
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acute malnutrition, severe illness, child being younger
than 6 months or older than 24 months and receipt of
vitamin A supplement within the last three months.
Study procedure
Before the start of fieldwork, chiefs, elders and other mem-
bers of the selected communities were informed about the
objectives of the study. This was followed by community
awareness and sensitization meetings in all 12 selected
communities about the objectives of the study and the role
micronutrients play in the health of children. Recruitment
of subjects began on 30th March 2009 after mothers of
children had been consented and recruited. At baseline,
socio-demographic information was collected; haemoglobin
levels were also determined for all study children. All chil-
dren were supplemented with vitamin A under direct ob-
servation by study fieldworkers. A baseline blood sample
was collected for determination of vitamin A status using
the modified relative dose response (MRDR) test 30 ± 7 days
after vitamin A was administered. The test involved admin-
istering 5.3 μmol 3,4-didehydroretinyl acetate dissolved in
corn oil to the child orally after which blood was taken 4–
6 hours later. MRDR values ≥0.060 indicated vitamin A de-
ficiency. Anthropometry (height/length and weight) was
also carried out at baseline prior to vitamin A supplementa-
tion and at end line following the end of zinc supplementa-
tion on 18th October 2009. A second blood draw was
carried out for MRDR and zinc analysis at end line after
which all participants were dosed with routine vitamin A
on completion of the study.
Morbidity follow-up
Follow up visits were made by fieldworkers to partici-
pants to check compliance to the study intervention and
to collect data on adverse events and recent illness. Mor-
bidity forms were completed by field workers at the end
of each week to collect date on signs and symptoms of
illnesses occurring during that week. Data was collect-
ed if a child was found to be unwell with fever (tempe-
rature ≥37.5°C) or if the mother reported a child’s illness
to a field worker, or if there was a history of fever within
the past 48 hours. Data was also collected on any other
acute illness such as diarrhea, fast breathing or cough in
which case the child was then immediately referred to
the study clinic and follow up morbidity forms were sub-
sequently completed for participants on days 7, 14 and
28 after hospital referral. Field workers were also taught
how to prepare blood slides to determine malaria parasit-
aemia if the child was found to have a temperature ≥37.5°C
or if there was a history of fever within the past 24 hours.
Field workers were instructed to put blood drops on filter
paper for Polymerase Chain Reaction (PCR) tests and the
dried blood spots were kept for future anti malarial drug
resistance analysis using genotyping. Haemoglobin mea-
surements were carried out on venous blood which had
been collected using an automated HemoCue Hb 201+
Blood Hemoglobin photometer, Angelholm, Sweden before
and at the end of the study and haemoglobin was regarded
as low if it was <10.0 g/dl [18]. The volume of plasma used
for analyses of plasma zinc was 0.5 ml and the assessment
was carried out at the Institut de Recherche en Sciences de
la Santé in Bobo Dioulasso, Burkina Faso using Shimadzu
Atomic Absorption Spectrophotometer AA-6300 (P/N
206–51800) Kyoto, Japan.
Sample size
The primary outcome was incidence of clinical malaria
and the sample size was based on the assumption that
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Figure 1 Trial profile of infants recruited into the trial and lost to follow up.
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there will be a reduction of the incidence of clinical mal-
aria of at least 20% among the children who were
supplemented with combined vitamin A and zinc com-
pared with those supplemented with vitamin A alone.
The significance level was set at p = 0.05 and the power
was 80%. Allowing for 10% lost to follow-up, the project
required a sample size of 200 children (100 per arm).
Blood sample analyses
Modified relative dose response test
The modified relative dose response (MRDR) test is a
biochemical technique used to indirectly determine vita-
min A liver reserves in the assessment of vitamin A sta-
tus in response to intervention trials. The blood samples
collected for the MRDR test were stored on ice away
from light in a cooler until transported to the laboratory.
Clotted blood samples were centrifuged at 600 × g for
10 min, and the serum samples were stored at −20°C
until shipped. The samples were analyzed for 3, 4-
didehydroretinol (DR) and retinol (R) using a standard-
ized method developed specifically for small serum
volumes using High Performance Liquid Chromatog-
raphy (HPLC), JASCO UV-2070 PLUS intelligent UV/
VIS Detector, LC-Net II/ADC, PU-2089 PLUS Quater-
nary Gradient Pump, Tokyo, Japan [19]. As liver vitamin
A reserves become depleted, apo-retinol binding protein
(RBP) accumulates in the liver. For the MRDR test, a
challenge dose of 3, 4-didehydroretinyl acetate is admin-
istered and the response of dehydroretinol-holo-RBP
complex is measured in the serum ~5 h after dosing
[20]. The MRDR test distinguishes between moderately
inadequate and adequate vitamin A status; MRDR
values ≤ 0.030 indicate vitamin A adequacy, 0.030 to
0.060 is uncertain vitamin A status, and MRDR ≥0.060
indicate vitamin A deficiency [21].
Plasma zinc analyses
Standards were run to obtain a calibration curve. The
plasma samples were allowed to thaw at room temperature
and each sample was gently mixed. 250 μl of the plasma
samples was pipetted into 10 ml tubes in duplicates and
topped up with 2.5mls n-butanol (6%). The tube was
covered with paraffin and vortexed for 3 sec. This was
centrifuged for 10 min at 3500 rpm at 21°C. The super-
natant was taken out and zinc content was measured. The
results were read against the standard calibration curve
to obtain the zinc concentration. For quality control
purposes controls (Level 1 & 2) were run against the
plasma samples [22].
Data management and statistical analyses
Field supervisors checked all forms manually for com-
pleteness and consistency. Forms were double entered in
computers, range and consistency checks were performed
and discrepancies resolved by reference to the original
form using Microsoft visual Foxpro version 9.0 Data Ma-
nagement Software. Clean data were analysed using Stata
version 11. Simple descriptive analysis of baseline mea-
sures (demographic, socioeconomic, biochemical) was
performed across the treatment groups to confirm their
comparability. Demographic characteristics of the subjects
that were categorical in nature were summarized as pro-
portions while continuous variables were summarized as
means. Differences in means of the MRDR tests between
intervention and controls were conducted at baseline and
end line using the t test. Anthropometric indices height-
for-age (HA), weight-for-age (WA) and weight-for- height
(WH) were expressed as z-scores using the WHO Anthro
for personal computers, Version 3.1, 2010: Software for
assessing growth and development of children. P < 0.05
was considered significant.
Ethical issues
Written informed consent was sought from all mothers
for participation of their children in the study after a de-
tailed explanation of the purpose, risks and benefits of
the study. Mothers who were literate signed the study
consent form but finger prints were obtained from
mothers who could not sign the consent forms; the
thumb printing was done in the presence of a witness.
The protocol was approved by the Institutional Ethics
Committee of the Kintampo Health Research Centre.
Office for Human Research Protections Federal Wide
Assurance number 00011103 registration number
0004854. The study was registered with Clinical Trials.
gov NCT01782001.
Results
Baseline characteristics
A comparison of the baseline data of the intervention
and the control groups showed that the two groups were
comparable with respect to their socio demographic
characteristics. An assessment of availability of amen-
ities, such as electricity and toilets in their homes,
showed that the two groups were not significantly differ-
ent and so was their usage of bed nets. The mean age of
enrolled children was similar at baseline and endline
(Table 1).
Anthropometry and haematological indices
There was no significant difference in anthropometric
indices between the intervention and control groups at
baseline and end line and when this was assessed a fur-
ther 6 months later, there was still no significant differ-
ence. Anaemia rates were not significantly different at
baseline and endline between the intervention and the
control groups. Plasma zinc levels were as expected
higher at end line in the intervention group compared to
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the control group but this was not statistically different.
They were fewer children in the intervention group
(23.9%) who were anaemic at end line compared to in-
fants in the control (29.4%) but this was not statistically
significant (p = 0.69) (Table 2).
Morbidity assessments and malaria parasitaemia
A number of childhood morbidities were assessed dur-
ing weekly visits from the start of supplementation until
the completion of the study which was the week 22-visit.
There was no significant difference between children in
the intervention and the control groups in any of the
conditions assessed during the visits. Geometric mean
parasites densities were compared at baseline and end
line and the intervention and the control groups did not
differ significantly at baseline. However, at end line it
was observed that there were consistently lower geomet-
ric mean parasite densities in the intervention group
compared to the control group for counts greater than
or equal to 2000 even though this was not statistically
significant; though the numbers of participants were
very small, counts between 5,000 and 10,000 were statis-
tically significant (p = 0.02) (Table 3).
Clinical malaria
The number of children who were diagnosed with un-
complicated malaria in the intervention group was 27%,
which was significantly lower than the children in the
control group p = 0.03. However, all other clinical condi-
tions assessed such as severe malaria, pneumonia, an-
aemia and diarrhoea were not found to be statistically
significant between the intervention and the control
groups (Table 4).
Discussion
We demonstrated in this randomised controlled trial
that giving a combination of vitamin A and zinc supple-
ments to children aged 6–24 months led to 27% signifi-
cantly fewer cases of clinical attacks compared to
children who were given vitamin A alone. This finding
suggests a role of zinc in reducing malaria morbidity
when given in addition to vitamin A; thus confirming
the findings of Zeba et al.14 which demonstrated 30%
fewer cases of clinical attacks.
Shankar et al. [23] demonstrated that vitamin A sup-
plementation of children 6 months to 5 years of age in
Papua New Guinea resulted in decreased malaria para-
site densities, severity of infection and febrile episodes,
which we also observed in our study. Several cross-
sectional studies have shown a relationship between low
zinc status and increased incidence of malaria [24,25].
Shankar et al. [26] and Bates et al. [27] have in a pooled
analysis demonstrated a 36% (95%CI:9-55%) reduction in
the incidence of clinical malaria in children given daily
doses of zinc supplements. However in a study in Gam-
bian children by Muller et al. [28], there was no signifi-
cant difference in the incidence of clinical malaria
between the daily zinc and placebo groups. Other studies
in Ghana by Binka et al. have not shown a significant ef-
fect of vitamin A on malaria parasitaemia rates or para-
site densities [29]. We observed that at end line a lower
percentage of infants in the intervention group had high
malaria parasite counts compared to infants in the con-
trol group and it is therefore not surprising that infants
in the intervention group had a lower incidence of clin-
ical malaria compared to infants in the control group
Table 3.
Table 1 Comparison of baseline characteristics of mothers
of children in the intervention and control groups
Intervention group Control group
n = 100 (%) n = 100 (%)
Mean age of child (mo)
Baseline (SD) 14.3 (6.6) 14.8 (6.1)
End line(SD) 19.7 (7.8) 20.8 (8.5)
Sex (%M) 51 (51.0) 44 (44.0)
Parity
1–3 51 (51.0) 42 (42.0)
4–6 30 (30.0) 33 (33.0)
>6 19 (19.0) 25 (25.0)
Occupation
Farmer/labourer 90 (90.0) 93 (93.0)
Professional 10 (10.0) 7 (7.0)
Mothers age
15–19 33 (33.0)33(33.0) 40 (40.0)
20–29 29 (29.0 37 (37.0)
30–45 5 (5.0)) 17 (17.0)
Not known 6 (6.0)
Highest education level
None 54 (54.0) 63 (63.0)
Primary 21 (21.0) 13 (13.0)
Middle 25 (25.0) 24 (24.0)
Ability to read
Yes 26 (26.0) 24 (24.0)
Bed net use
Yes 94 (94.0) 95 (95.0)
Electricity available 2 (2.0) 7 (7.0)
Toilets available 65 (65.0) 64 (64.0)
Drinking water
Communal tap 66 (66.0) 66 (66.0)
Ground well 6 (6.0) 6 (6.0)
Stream 28 (28.0) 28 (28.0)
No significant difference was noted among treatment groups for all characteristics.
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Our study also showed a modest effect of vitamin and
zinc supplementation on weight and length/height gain
of the children involved in the study but this was not
statistically significant and the reasons for this are not
clear. This finding is also similar to results obtained by
Rahman et al. [30] in Bangladeshi children between the
ages of 12–35 months. The authors concluded that com-
bined short-term zinc supplementation and a single dose
of vitamin A had no significant change on weight and
length increments in children over a 6-month period.
Studies in Danish infants have shown an increase in an-
thropometric indices between the ages of 6–9 months
among infants supplemented with zinc [31] but two
other studies showed that low zinc intake did not impair
growth [32,33]. We did not find any significant differ-
ences in the anthropometric indices of those who were
supplemented with zinc and the reasons for this are not
too clear.
Humans have no body store for zinc, and bioavailable
zinc must be supplied on a regular basis [34]. Zinc defi-
ciency in infancy and early childhood in developing
countries leads to stunting [35], infectious disease mor-
bidity [36] and mortality [37] especially from diarrhoea
and pneumonia.
Table 2 Infant anthropometric, vitamin A status, haematologic and anaemia indexes at baseline and end of study
Intervention (n = 100) Control (n = 100) p
Baseline anthro.
Child weight (kg) 8.6 (8.3, 8.9) 8.7 (8.4, 9.1) 0.68
Child height (cm) 74.4 (73.1, 75.8) 75.1 (73.8, 76.3) 0.51
Height for agea −0.95 ± 1.01 (−1.15, -0.75) −1.0 ± −0.96 (−1.22, -0.84) 0.57
Weight for agea −1.1 ± 0.92 (−1.27, -0.89) −1.1 ± 1.0 (−1.3, -0.89) 0.90
Weight for heighta −0.81 ± 0.80 (−0.97, -0.64) −0.8 ± 1.1 (−0.96, -0.53) 0.67
Endline anthro.
Child weight(kg) 10.3 (9.3, 11.3) 10.4 (9.4, 11.5) 0.88
Child height (cm) 89.6 (69.0, 78.2) 79.9 (78.6, 81.1) 0.34
Height for agea −1.4 ± 1.41 (−1.68, -1.08) −1.3 ± 1.50 (−1.70, -1.10) 0.95
Weight for agea −0.83 ± 3.13 (−1.49, -0.16) −0.76 ± 3.18 (−1.42, -0.10) 0.87
Weight for heighta −0.16 ± 4.26 (−1.10, -0.74) −0.10 ± 4.37 (−0.98, -0.83) 0.90
Final anthro.
Child weight (kg) 11.2 (10.8, 11.6) 11.2 (10.8, 11.6) 0.94
Child Height (cm) 85.0 (83.8, 86.1) 84.8 (83.4, 86.2) 0.84
Height for agea 0.86 ± 1.33 (0.56, 1.16) 1.19 ± 2.48 (0.65, 1.72) 0.31
Weight for agea 0.34 ± 0.37 (−0.40, 1.08) 0.54 ± 0.41 (−0.27, 1.35) 0.72
Weight for heighta −0.05 ± 0.48 (−1.01, 0.92) −0.13 ± 0.45 (−1.02, 0.76) 0.90
Baseline indices
Haem (g/dL) 10.7 (10.4,11.0) 10.8 (10.5, 11.0) 0.84
Anaemia (n%) b 28/100 (28.0) 31/100 (31) 0.64
Low Vit. A statusy 59/64 (92.2) 42/47 (89.4) 0.61
Adequate Vit A statusχ 1/64 (1.6) 0/47 (1.6) 0.39
Plasma zinc(μg/dl) 81 (72, 90) 69 (57, 81) 0.10
End line indices
Haem. (g/dL) 10.9 (10.5, 11.2) 10.8 (10.5, 11.2) 0.93
Anaemia (n%)b 21/88 (23.9%) 27/92 (29.4%) 0.69
Low vit. A statusy 45/57 (78.9) 37/43 (86.1) 0.36
Adequate vit A statusχ 1/57 (1.8) 1/43 (2.3) 0.84
Received vit A in 6 months 96/100 (96.0) 95/100 (95.0) 0.50
Plasma zinc (μg/dl) 63 (52, 73) 58 (49, 66) 0.48
a- χ ± SD; range in parenthesis (all such values).
b. Defined as haemoglobin concentration <10 g/dl.
y-low vitamin A status MRDR ≥ 0.06.
χ-Adequate vitamin A status MRDR ≤ 0.03.
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Pooled analyses of four randomised controlled trials by
the Zinc Collaborative Group showed a 41% reduction
in the incidence of pneumonia [38]. In a study in
Bangladesh assessing the interaction of the combination
of vitamin A and zinc in the prevention of acute lower
respiratory infections (ALRI), there was an increased
relative risk of ALRI in the zinc supplemented children
(RR 1.06, 95% CI 1.01-2.25) when compared to placebo
[39] but we are unable to confirm or deny these finding
because the number of respiratory diseases reported in
our study were low.
There is undisputed evidence of the efficacy of zinc for
the treatment of childhood diarrhoea and this has been
confirmed by the results of pooled analyses of seven
studies in children under the age of five years38. Gupta
et al. supplemented children 6–41 months of age with
10 mg zinc five times a week and it was observed that
children who received this had significantly lower rates
of diarrhoea during the period of supplementation [40];
however, our study did not demonstrate any significant
difference in the incidence of diarrhoea between the
intervention and control groups.
We observed a modest increase in plasma zinc levels
from baseline to end line, but this was not statistically
significant. Similar findings have been described by Lo
et al. [41] who found that plasma zinc concentration in-
creased in children who received daily zinc supplemen-
tation for but not in those who received zinc with
complementary foods suggesting the role of inhibitors in
absorption.
Our study was conducted in an area where the
mothers were of low socioeconomic status. More than
90% of children received a dose of vitamin A in the past
6 months. It is important to note that even though the
children had been given vitamin A, vitamin A analyses
showed that most of them still remained vitamin A defi-
cient Table 2.
A limitation of the study was that the fact that the
intervention was self administered, the weekly visits may
not have adequately captured compliance to the inter-
vention and the study was powered to look at the inci-
dence of clinical malaria and so may not have been
adequately powered to detect the effect of supplementa-
tion on other indices.
Table 3 Comparison of geometric mean malaria parasite densities at baseline and end line
Parasite count Observations Parasite densities (95%CI) p
Intervention Control Intervention Control
Baseliney
<2000 17 15 491 (288,838) 542 (310,949) 0.78
≥2000& < 5000 7 8 2732 (2196,3381) 3285 (2839,3802) 0.10
≥5000& < 10000 11 6 7473 (6488,8608) 6517 (5085,8351) 0.23
≥10000 12 19 25263 (16019,39842) 33042 (22825,47831) 0.33
Total 47 48 3281 (1956,5501) 5084 (2932,8811) 0.24
EndlineX
<2000 8 7 576 (245,1354) 390 (146,1037) 0.48
≥2000& < 5000 4 5 2495 (2053,3547) 3175 (2428,4154) 0.08
≥5000& < 10000 4 3 6973 (5856,8303) 8863 (7238,10854) 0.02
≥10000 3 7 24485 (6625,90491) 33739 (18049,63068) 0.49
Total 19 22 2397 (1119, 5135) 3976 (1659,9257) 0.37
Y 105 out of 200 children had no malaria parasites at baseline.
X-159 out of 182 children who completed follow up had no malaria parasites at end line.
Table 4 Impact of supplementation on malaria and general morbidity
Morbidity Intervention (87) Control (88) RR (95%CI) p
n (%) n (%)
Uncomplicated Malaria 40 (46.0) 55 (62.5) 0.73 (0.55, 0.97) 0.03
Severe malaria 1 (1.1) 1 (1.1) 0.99 (0.06, 15.9) 0.99
Non severe pneumonia 3 (3.4) 1 (1.1) 3.03 (0.32,28.6) 0.33
Severe pneumonia 0 1 (1.1) - -
Acute diarrhoea 9 (10.3) 7 (7.9) 1.30 (0.51,3.33) 0.58
Bloody diarrhoea 7 (8.0) 4 (4.5) 1.77 (0.54,5.83) 0.34
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Our study showed that it was safe to administer vita-
min A and zinc to infants as there were no reports of
adverse events associated with administering zinc and
vitamin A supplements, findings that have been con-
firmed by Walker and Black [42].
Conclusions
This study revealed the critical role played by micro-
nutrients, such as vitamin A and zinc, in the reduction
of clinical attacks of malaria in young children. Malaria
remains a leading cause of morbidity and mortality
among young children in developing countries and im-
poses a huge economic and social burden and any
methods that can be used to reduce this burden should
be explored.
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